×
AxoGen EBITDA 2010-2025 | AXGN
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
AxoGen ebitda from 2010 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
View More
AxoGen EBITDA 2010-2025 | AXGN
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
AxoGen ebitda from 2010 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company Name
Market
Cap
Thermo Fisher Scientific (TMO)
$184.3B
Intuitive Surgical (ISRG)
$168.9B
IDEXX Laboratories (IDXX)
$51.3B
Edwards Lifesciences (EW)
$47.5B
Alcon (ALC)
$40.1B
IQVIA Holdings (IQV)
$32.1B
DexCom (DXCM)
$30B
Mettler-Toledo (MTD)
$26.5B
STERIS (STE)
$24.5B
Waters (WAT)
$17.5B
SONOVA HOLDING (SONVY)
$17B
Hologic (HOLX)
$14.8B
Penumbra (PEN)
$10.4B
Globus Medical (GMED)
$8.3B
Sysmex ADR (SSMXY)
$8.1B
Masimo (MASI)
$7.7B
Teleflex (TFX)
$5.7B
Glaukos (GKOS)
$5.5B
TransMedics (TMDX)
$4B
Integer Holdings (ITGR)
$3.8B
LivaNova (LIVN)
$3.1B
Alphatec Holdings (ATEC)
$2.4B
PROCEPT BioRobotics (PRCT)
$2.3B
Veracyte (VCYT)
$2.3B
Artivion (AORT)
$2.1B
Nihon Kohden (NHNKY)
$1.9B
Elekta AB (EKTAY)
$1.9B
Integra LifeSciences Holdings (IART)
$1.2B
OPKO Health (OPK)
$1.1B
Paragon 28 (FNA)
$1.1B